Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Edmonton
Clinical trial register · Canada

Clinical Trials in Edmonton, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3491
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Montreal 13 Toronto 9 Edmonton 6 Vancouver 6 London 4
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University of Alberta177 AstraZeneca52 AbbVie36 National Cancer Institute (NCI)27 Merck Sharp & Dohme LLC26 Janssen Research & Development, LLC22 Pfizer21 AHS Cancer Control Alberta21 Canadian Cancer Trials Group21 Novartis Pharmaceuticals20 University of Calgary19 Children's Oncology Group19 Bristol-Myers Squibb16 Sanofi15 Hoffmann-La Roche14 Eli Lilly and Company14 Incyte Corporation11 Novo Nordisk A/S10 University Health Network, Toronto9 University of British Columbia9 Regeneron Pharmaceuticals8 Population Health Research Institute8 GlaxoSmithKline8 Amgen8 Alexion Pharmaceuticals, Inc.7 Show all 290 Clear sponsor filter
Site location
Montreal13 Toronto9 Edmonton6 Vancouver6 London4 Calgary4 Multiple Locations3 Many Locations3 Hamilton3 Sherbrooke3 Halifax3 Saskatoon2 Mount Royal1 Brampton1 Ottawa1 Québec1 Burlington1 Abbotsford British Columbia1 Victoria1
All 19 locations
Target enrolment
to

Trials with a site in Edmonton

6 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
Bayer
Phase 3
117
Edmonton, Vancouver, London, Toronto, Montreal, Saskatoon
2026-06-01
Recruiting
Bayer
Phase 3
111
Edmonton, Vancouver, London, Toronto, Montreal, Saskatoon
2025-11-19
Recruiting
Bayer
Phase 1
148
Toronto, Montreal, Sherbrooke, Edmonton
2025-02-28
Recruiting
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
NCT06217822Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Bayer
Phase 1
198
Edmonton, Vancouver, Hamilton, Toronto, Montreal, Sherbrooke
2024-03-07
Active, closed
Bayer
Phase 3
985
Calgary, Edmonton, Abbotsford British Columbia, Vancouver, Victoria, Halifax, Hamilton, London
2023-04-03
Active, closed
Bayer
Phase 3
774
Calgary, Edmonton, Halifax, Burlington, London, Toronto, Montreal, Sherbrooke
2020-10-20
Rows per page Showing 1–6 of 6
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 15 November 2026. https://priyalifescience.com/clinical-trials-canada/city/edmonton

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 13 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 6 of those studies with a site in Edmonton that also match the filters currently applied.

How many clinical trials are recruiting in Edmonton?

4 of the 6 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Edmonton), 6 studies
PhaseStudiesRecruitingShare
Phase 34266.7%
Phase 12233.3%

Most active sponsors

Lead sponsors with the most studies (Edmonton)
Lead sponsorStudiesRecruiting
Bayer64
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.